comparemela.com

Page 3 - Gerry Mcelvaney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ireland s first Covid-19 treatment trial reveals potential of AAT

The Irish study is the first to trial the protein AAT in the treatment of acute respiratory distress, which occurs in severe Covid-19 cases.

Oliver mcelvaneyGerry mcelvaneyUniversity of medicineHealth sciencesBeaumont hospitalProf gerry mcelvaney

Irish clinical trial reveals new treatment option for COVID-19

An anti-inflammatory protein, alpha-1 antitryspin, may treat patients who have developed acute respiratory distress syndrome as a result of COVID-19

Oliver mcelvaneyGerry mcelvaneyNatalie mcevoyDepartment of critical careUniversity of medicineDepartment of anaestheticsSenior clinical research nurseIreland universityDepartment of medicineRoyal college of surgeonsHealth sciencesRoyal collegeBeaumont hospitalCritical careProfessor ger curley

Potential New Treatment Option for COVID-related ARDS

New clinical trial findings suggest alpha-1 antitrypsin could be an effective treatment for COVID-related acute respiratory distress syndrome.

Oliver mcelvaneyGerry mcelvaneyNatalie mcevoyDepartment of critical careUniversity of medicineDepartment of medicineHealth sciencesBeaumont hospital dublinBeaumont hospitalWell toleratedCritical careAcute respiratory distress syndromeCute respiratory distress syndrome ardsAdult respiratory distress syndromeRds acute respiratory distress syndromeRespiratory distress syndrome

Could AAT be the answer to COVID-19 ARDS?

Clinical study finds alpha-1 antitryspin (AAT) reduces pro-inflammatory IL-6 and therefore may benefit COVID-19 patients with Acute Respiratory Distress Syndrome (ARDS).

Oliver mcelvaneyGerry mcelvaneyUniversity of medicineDepartment of medicineHealth sciencesAcute respiratory distress syndromeBeaumont hospital

vimarsana © 2020. All Rights Reserved.